TNXP — Tonix Pharmaceuticals Holding Share News
0.000.00%
Last trade - 00:00- $88.67m
- -$87.56m
- $13.11m
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology
U.S. STOCKS ON THE MOVE-American Express, Deckers, Q32 Bio
Tonix rises on Medicare coverage expansion for chronic pain treatment
Brief: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives
Tonix Pharmaceuticals Q1 net loss widens on higher SG&A expenses
Brief: Tonix Pharmaceuticals Announces Presentations At World Vaccine Congress Washington 2026
Tonix Pharmaceuticals Q4 revenue more than doubles, net loss widens
Brief: Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market To Nasdaq Global Select Market
U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
U.S. STOCKS ON THE MOVE-Charter Communications, Western Digital, Regeneron
U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology
Tonix pain‑relief drug meets main goal in late‑stage study; shares fall
Tonix Pharmaceuticals ticks up after $20 million direct stock deal
Brief: Tonix Pharmaceuticals Announces Licensing TNX-4900